Comparing Bydureon vs Mounjaro
| Bydureon (exenatide) | Mounjaro (tirzepatide) |
|
|---|
| Bydureon (exenatide) | Mounjaro (tirzepatide) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Type 2 Diabetes. Bydureon may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Type 2 Diabetes. Mounjaro may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
Popular comparisons
|
|||||||
| More about Bydureon (exenatide) | More about Mounjaro (tirzepatide) | ||||||||
| Ratings & Reviews | |||||||||
|
Bydureon has an average rating of 6.3 out of 10 from a total of 270 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 26% reported a negative effect. |
Mounjaro has an average rating of 8.5 out of 10 from a total of 1301 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Bydureon side effects |
View all Mounjaro side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Lower cost generic approved | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Mounjaro prices |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other exenatide brands include: Bydureon BCise, Byetta | Other tirzepatide brands include: Zepbound | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
2.4 hours |
120 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 373 drugs are known to interact with Bydureon:
|
A total of 414 drugs are known to interact with Mounjaro:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
January 27, 2012 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.